Cite
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.
MLA
Gillessen, Silke, et al. “Management of Patients with Advanced Prostate Cancer-Metastatic and/or Castration-Resistant Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.” European Journal of Cancer (Oxford, England : 1990), vol. 185, May 2023, pp. 178–215. EBSCOhost, https://doi.org/10.1016/j.ejca.2023.02.018.
APA
Gillessen, S., Bossi, A., Davis, I. D., de Bono, J., Fizazi, K., James, N. D., Mottet, N., Shore, N., Small, E., Smith, M., Sweeney, C. J., Tombal, B., Antonarakis, E. S., Aparicio, A. M., Armstrong, A. J., Attard, G., Beer, T. M., Beltran, H., Bjartell, A., … Omlin, A. (2023). Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022. European Journal of Cancer (Oxford, England : 1990), 185, 178–215. https://doi.org/10.1016/j.ejca.2023.02.018
Chicago
Gillessen, Silke, Alberto Bossi, Ian D Davis, Johann de Bono, Karim Fizazi, Nicholas D James, Nicolas Mottet, et al. 2023. “Management of Patients with Advanced Prostate Cancer-Metastatic and/or Castration-Resistant Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.” European Journal of Cancer (Oxford, England : 1990) 185 (May): 178–215. doi:10.1016/j.ejca.2023.02.018.